Tetsuro Yoshimaru
Osaka, 5670085, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
A one-step, resin-compatible Cys-Trp cross-linking system opens a new avenue for stapled peptide therapeutics.
Journal: Bioorganic & medicinal chemistry
Published: February 05, 2026
Crucial roles of GALNT6-mediated O-glycosylation of GRP78/Bip in proliferation of breast cancer cells.
Journal: Biochemical and biophysical research communications
Published: July 17, 2025
p53-independent tumor suppression by cell-cycle arrest via CREB/ATF transcription factor OASIS.
Journal: Cell reports
Published: October 11, 2022
Functional genomics for breast cancer drug target discovery.
Journal: Journal of human genetics
Published: March 30, 2021
Biophysical characterization of the breast cancer-related BIG3-PHB2 interaction: Effect of non-conserved loop region of BIG3 on the structure and the interaction.
Journal: Biochemical and biophysical research communications
Published: July 24, 2019
The GALNT6‑LGALS3BP axis promotes breast cancer cell growth.
Journal: International journal of oncology
Published: May 20, 2019
Frequent downregulation of LRRC26 by epigenetic alterations is involved in the malignant progression of triple-negative breast cancer.
Journal: International journal of oncology
Published: September 13, 2017
A DDX31/Mutant-p53/EGFR Axis Promotes Multistep Progression of Muscle-Invasive Bladder Cancer.
Journal: Cancer research
Published: August 21, 2017
Stapled BIG3 helical peptide ERAP potentiates anti-tumour activity for breast cancer therapeutics.
Journal: Scientific reports
Published: February 07, 2017
A-kinase anchoring protein BIG3 coordinates oestrogen signalling in breast cancer cells.
Journal: Nature communications
Published: September 26, 2016
Last Updated: 09/26/2026